OncoSec Medical Analysis
| ONCSDelisted Stock | USD 0.0002 0.00 0.00% |
OncoSec Medical is overvalued with Real Value of 1.9E-4 and Hype Value of 2.5E-4. The main objective of OncoSec Medical delisted stock analysis is to determine its intrinsic value, which is an estimate of what OncoSec Medical is worth, separate from its market price. There are two main types of OncoSec Medical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect OncoSec Medical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of OncoSec Medical's stock to identify patterns and trends that may indicate its future price movements.
The OncoSec Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. OncoSec Medical is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. OncoSec Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and OncoSec Medical's ongoing operational relationships across important fundamental and technical indicators.
OncoSec |
OncoSec Stock Analysis Notes
About 28.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.78. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. OncoSec Medical recorded a loss per share of 20.31. The entity last dividend was issued on the 21st of May 2019. The firm had 1:22 split on the 9th of November 2022. OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company was incorporated in 2008 and is headquartered in Pennington, New Jersey. Oncosec Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 54 people. To find out more about OncoSec Medical contact Robert Arch at 855 662 6732 or learn more at https://oncosec.com.OncoSec Medical Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. OncoSec Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding OncoSec Medical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| OncoSec Medical is not yet fully synchronised with the market data | |
| OncoSec Medical has some characteristics of a very speculative penny stock | |
| OncoSec Medical has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (34.18 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| OncoSec Medical currently holds about 19.48 M in cash with (32.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.5, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 28.0% of the company outstanding shares are owned by corporate insiders |
OncoSec Medical Upcoming and Recent Events
Earnings reports are used by OncoSec Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to OncoSec Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of June 2023 Upcoming Quarterly Report | View | |
| 30th of April 2023 Next Fiscal Quarter End | View |
OncoSec Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.65 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate OncoSec Medical's market, we take the total number of its shares issued and multiply it by OncoSec Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.OncoSec Medical Predictive Daily Indicators
OncoSec Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of OncoSec Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 2.0E-4 | |||
| Day Typical Price | 2.0E-4 | |||
| Relative Strength Index | 34.01 |
About OncoSec Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how OncoSec Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling OncoSec shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as OncoSec Medical. By using and applying OncoSec Stock analysis, traders can create a robust methodology for identifying OncoSec entry and exit points for their positions.
OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company was incorporated in 2008 and is headquartered in Pennington, New Jersey. Oncosec Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 54 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding OncoSec Medical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the OncoSec Medical information on this page should be used as a complementary analysis to other OncoSec Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in OncoSec Stock
If you are still planning to invest in OncoSec Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoSec Medical's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |